Health Canada approves drug to treat COVID-19 in immunocompr

Health Canada approves drug to treat COVID-19 in immunocompromised patients, AstraZeneca says

Some people in Canada who are particularly vulnerable to illness from COVID-19 have a new treatment option. The antibody-based therapy Evusheld previously used to prevent the virus can now also be used as a treatment.

Related Keywords

United Kingdom , Canada , British , Zain Chagla , Mahyar Etminan , Astrazeneca , Mcmaster University , University Of British Columbia , Health Canada , British Columbia ,

© 2025 Vimarsana